BioSpace News Archive

Fourth quarter results driven by 10.1% year-over-year growth in home care revenue and operating margin improvement to 17.3%

More exam rooms and soon walk-in appointments at new Children’s clinic

ASC40, an orally bioavailable, first-in-class inhibitor of fatty acid synthase, is currently in a global Phase 2 trial in NASH of which the first patient was dosed in late April, 2019 in the USA.

Savii continues to implement meaningful integrations so their customers have embedded access to tools they need to become and stay leaders in the industry.

Medtec China 2019 will be inaugurated on September 25 in Shanghai.

The hospital is expected to start providing services in the third quarter of 2021.

An “off” episode is a time when a patient’s medications are not working well, causing an increase in PD symptoms, such as tremor and difficulty walking.

Commercial Performance Data from the European Registry on more than 3,000 Eversense® Commercial Users Found Low Related Adverse Events over Multiple Sensor Cycles in the Real-World Setting

MNA nurses and healthcare professionals who are part of a large coalition of patients, families, providers, advocates and elected officials fighting to preserve local behavioral health care in Greenfield, Palmer and Westfield called on Baystate Health to dissolve its partnership with US HealthVest following a Seattle Times investigation into the for-profit company and Baystate’s decision to “review” its partnership with the company.

The Company’s unaudited fiscal Q1 2020 condensed interim consolidated financial statements and MD&A are available on SEDAR.